BPC-157 (Body Protection Compound-157).
What is BPC-157?
BPC-157 is a synthetic 15-amino acid peptide derived from human gastric juice, widely studied in animals for its potent regenerative, anti-inflammatory, and wound-healing properties
. It is primarily used for accelerating recovery from muscle, tendon, and ligament injuries. While showing promise for GI issues and tissue repair, it is not FDA-approved and lacks comprehensive human clinical trials.
National Institutes of Health (.gov) +3
Benefits and Therapeutic Potential
Rapid Injury Healing: Accelerates healing of tendons, ligaments, and muscles by promoting angiogenesis (new blood vessel formation) and fibroblast activity.
Anti-inflammatory/GI Health: Acts as an anti-ulcer agent and treats inflammatory bowel disease (IBD) by strengthening the gastric mucosa
.
Tissue Protection: Demonstrates protective effects on organs, including the liver and heart, and has potential neuroprotective properties.
Systemic Recovery: Used off-label by athletes for muscle strain, joint pain, and ligament injuries.
National Institutes of Health (.gov) +4
Mechanism of Action
BPC-157 works by modulating nitric oxide (NO) synthesis, up-regulating growth factors, and influencing collagen production. It enhances the repair of poorly vascularized tissues (like tendons) by promoting the expression of VEGFR2 and Akt-eNOS pathways, which are critical for forming new blood vessels.
National Institutes of Health (NIH) | (.gov) +2
Forms and Administration
Injectable: Most common, often injected subcutaneously or intramuscularly.
Oral: Stable in human gastric juice, making it effective when taken orally for gastrointestinal issues.
Topical/Other: Sometimes available as creams or nasal sprays.
National Institutes of Health (.gov) +4
Safety and Side Effects
Preclinical studies (in animals) have shown little to no toxicity. However, because human data is extremely limited, long-term side effects are unknown. There are theoretical concerns that its ability to promote new blood vessels could promote cancer.
www.usada.org +4
Regulation
BPC-157 is considered an experimental compound and is not approved for human use by the FDA. The World Anti-Doping Agency (WADA) has investigated it, and while not currently on the prohibited list, its use is considered high-risk. It is often sold online as a "research chemical," which carries significant risks regarding purity and manufacturing quality.